Skip to content

   
Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
Latest news
> 28 November 2008 : MedImmune Receives FDA Complete Response Letter on Motavizumab
> 25 November 2008 : AstraZeneca Provides Update on Agreement with Abraxis Biosciences for Co-Promotion of Abraxane in the US
> 25 November 2008 : AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva
Features
> 9 November 2008: Crestor JUPITER study results
Read more about our new Code of Conduct, which reflects our continued commitment to doing business the right way.
AstraZeneca websites
Search
Quick links
Information for
US visitors
Share price
> London
> New York
> Stockholm
AstraZeneca news feed
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008